English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Pharmaceutical
Patient Daily
| Dec 22, 2025
PhRMA Director on 340B: Hospitals are 'exploiting the program for profit'
Trending
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+
Pharmaceuticals
Patient Daily
| Jan 30, 2026
Senate gridlock delays decision on rare disease priority review voucher program
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
FDA extends review timelines for four priority voucher drugs
